Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Genome-wide off-target analyses of CRISPR/Cas9-mediated T-cell receptor engineering in primary human T cells.
Clin Transl Immunology. 2022 Jan 23;11(1):e1372. doi: 10.1002/cti2.1372. eCollection 2022.
Clin Transl Immunology. 2022.
PMID: 35106156
Free PMC article.
Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell Function.
Blaeschke F, Ortner E, Stenger D, Mahdawi J, Apfelbeck A, Habjan N, Weißer T, Kaeuferle T, Willier S, Kobold S, Feuchtinger T.
Blaeschke F, et al. Among authors: habjan n.
Front Immunol. 2022 Apr 6;13:845499. doi: 10.3389/fimmu.2022.845499. eCollection 2022.
Front Immunol. 2022.
PMID: 35464394
Free PMC article.
Item in Clipboard
Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins.
Blaeschke F, Stenger D, Apfelbeck A, Cadilha BL, Benmebarek MR, Mahdawi J, Ortner E, Lepenies M, Habjan N, Rataj F, Willier S, Kaeuferle T, Majzner RG, Busch DH, Kobold S, Feuchtinger T.
Blaeschke F, et al. Among authors: habjan n.
Blood Cancer J. 2021 Jun 4;11(6):108. doi: 10.1038/s41408-021-00499-z.
Blood Cancer J. 2021.
PMID: 34088894
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite